Notable Upgrades: Facebook (FB), Inotek Pharma (ITEK), PayPal Holdings (PYPL), LinkedIn (LNKD), BlackBerry (BBRY)

Facebook, Inc. (FB) was reiterated a ‘Buy’ by Axiom Capital analysts on Tuesday. The broker also raised its price target on the stock to $117 from $105 ahead of earnings tomorrow afternoon. The firm anticipates upside to estimates as checks throughout the quarter have been positive.

Facebook Inc. Cl A shares are currently priced at 91.82x this year’s forecasted earnings, which makes them quite expensive compared to the industry’s 18.63x earnings multiple. Ticker has a forward P/E of 35.49 and t-12 price-to-sales ratio of 19.58. EPS for the same period is $1.03.

In the past 52 weeks, shares of Menlo Park, California-based company have traded between a low of $70.32 and a high of $99.24 and are now at $94.85. Shares are up 25.24% year-over-year and 20.70% year-to-date.

Inotek Pharmaceuticals Corporation (ITEK) was reiterated as ‘Overweight’ with a $29 from $9 price target on Tuesday by Piper Jaffray.

ITEK shares recently gained $1.48 to $18.24. The stock has gained roughly 179% year-to-date. In the past 52 weeks, shares of Lexington, Massachusetts-based clinical-stage biopharmaceutical company have traded between a low of $4.68 and a high of $19.45.

Inotek Pharmaceuticals Corporation closed Monday at $16.76. The firm has a current market cap of $297.82 million.

In a report published Tuesday, Jefferies analysts initiated coverage on PayPal Holdings, Inc. (PYPL) with a ‘Buy‘ rating.

PYPL shares recently gained $1.16 to $37.55. In the past couple of weeks, shares of San Jose, California-based company have traded between a low of $33.98 and a high of $42.55. Shares are down 0.87% year-to-date.

Currently there are 14 analysts that rate PYPL a ‘Buy’, 8 rate it a ‘Hold’. 2 analysts rate it a ‘Sell’. PYPL has a median Wall Street price target of $45.00 with a high target of $50.00.

PayPal Holdings, Inc. operates independently of eBay Inc. (EBAY) as of July 17, 2015.

Shares of LinkedIn Corporation (LNKD) are up $5.90, or 2.67%, at $226.56, after MKM Partners analysts today initiated coverage of the name, giving it a ‘Buy‘ rating and price target of $285.

On valuation measures, LNKD shares have a forward P/E of 67.43 and t-12 price-to-sales ratio of 11.66. EPS for the same period is ($0.37).

In the past 52 weeks, shares of Mountain View, California-based firm have traded between a low of $176.83 and a high of $276.18. Shares are up 24.36% year-over-year ; down 3.94% year-to-date.

BlackBerry (BBRY) shares are up nearly 6% to $7.71 in midday trading after analysts at Morgan Stanley (MS) this morning upgraded the smartphone maker to ‘Equal-Weight’ from ‘Underweight’ and maintained their $7 price noting cash flexibility and cost-cutting initiatives will drive stock price value.

Be the first to comment

Leave a Reply

Your email address will not be published.


*